Children's Tumor Foundation and DELopen increase access to compounds for neurofibromatosis

(Children's Tumor Foundation) The Children's Tumor Foundation (CTF), an innovative and global neurofibromatosis research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries. DELopen will provide researchers free access to billions of molecules to seek insights into and develop therapies for the treatment of NF under grants covered by CTF's Discovery Fund.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news